AVANIR Pharmaceuticals (AMEX: AVN.R) completed the submission of its new drug application (NDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE